From immunosuppression to tolerance

Slides:



Advertisements
Similar presentations
Transplant Immunobiology
Advertisements

Innate Immunity (part 1) BIOS 486A/586A
Principles of Immunology The Inflammatory Process 4/6/06 "Life is not measured by the number of breaths we take, but by those special moments that take.
T cell-mediated immunity Chapter 8
Biochemical Markers in the inflammatory response Dr Claire Bethune Consultant Immunologist Derriford Hospital.
1 Transplantation therapy for terminal organ failure or tissue damage by transfer of healthy organ or tissue ( graft) donor - the individual who provides.
1 Circulating T cells Ag in the Inflammatory tissue Ch 9 T Cell-Mediated Immunity Ag-specific T cell response.
ORGANIZATION OF THE IMMUNE SYSTEM different cell types diffuse communication network between cells ‚signal transduction’ and inhibition similarity to the.
Lecture 16 Cellular Cooperation and Antigen Recognition
Activation of T Lymphocytes
Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients  Nazia Selzner, Maha Guindi, Eberhard.
INNATE IMMUNITY/ MUCOSAL IMMUNOLOGY REVIEW
Immunology Lecture 4 Development of B and T lymphocytes
Cell-Mediated Immunity
Thymocyte development summary
Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challenges  Marie-Louise Michel, Qiang Deng,
Mononuclear phagocytes in Immune Defence
Transplantation Immunology
Transplantation David Straus, Ph.D. Objectives
Transplant rejection: T-helper cell paradigm
Transplant: immunology and treatment of rejection
Immunotherapy of hepatocellular carcinoma
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Autoimmune hepatitis – Update 2015
Figure 3 Neutrophils in liver inflammation
The yin and yang of evasion and immune activation in HCC
The inflammasome in liver disease
Msc clinical immunology
T cell mediated immunity
Immunologic Basis of Graft Rejection and Tolerance Following Transplantation of Liver or Other Solid Organs  Alberto Sánchez–Fueyo, Terry B. Strom  Gastroenterology 
Volume 57, Issue 1, Pages 6-8 (July 2012)
Figure 1 Immune mechanisms in liver homeostasis
Agustín Albillos, Margaret Lario, Melchor Álvarez-Mon 
Volume 49, Issue 5, Pages (November 2008)
Roles for Chemokines in Liver Disease
Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients  Nazia Selzner, Maha Guindi, Eberhard.
Regulatory T-cell directed therapies in liver diseases
Malaria Vaccine Design: Immunological Considerations
Nicolas Moniaux, Jamila Faivre  Journal of Hepatology 
Chapter 14 Immune Response in Space and Time
Gut–liver immunity Journal of Hepatology
Transplantation Rejection of foreign tissue grafts is due to immune responses to alloantigens on the graft Blood group antigens Polymorphic MHC antigens.
Nat. Rev. Nephrol. doi: /nrneph
Regulatory T-cell directed therapies in liver diseases
Signalling pathways in alcohol-induced liver inflammation
Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challenges  Marie-Louise Michel, Qiang Deng,
Volume 53, Issue 4, Pages (October 2010)
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
The yin and yang of evasion and immune activation in HCC
Volume 45, Issue 4, Pages (October 2006)
Autophagy and senescence in fibrosing cholangiopathies
Dendritic cells: regulators of hepatic immunity or tolerance?
Veronika Lukacs-Kornek, Detlef Schuppan  Journal of Hepatology 
Cell Mediated Immunity
Cannabinoid signaling and liver therapeutics
Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients  Nazia Selzner, Maha Guindi, Eberhard.
Adiponectin: an enlarging role in acute kidney injury
Arjan Boltjes, Dowty Movita, André Boonstra, Andrea M. Woltman 
A Role for Th17 Cells in the Immunopathogenesis of Atopic Dermatitis?
Deciphering and Reversing Tumor Immune Suppression
Macrophage heterogeneity in liver injury and fibrosis
Silvia Affò, Ramón Bataller  Journal of Hepatology 
Volume 71, Issue 12, Pages (June 2007)
T Cell Activation and proliferation
Learning Tolerance while Fighting Ignorance
Dendritic Cells in Transplantation—Friend or Foe?
Vaccines for Lung Cancer
Volume 61, Issue 2, Pages (August 2014)
The future of biologics: Applications for food allergy
Woo-Yong Lee, Paul Kubes  Journal of Hepatology 
Presentation transcript:

From immunosuppression to tolerance David H. Adams, Alberto Sanchez-Fueyo, Didier Samuel  Journal of Hepatology  Volume 62, Issue 1, Pages S170-S185 (April 2015) DOI: 10.1016/j.jhep.2015.02.042 Copyright © 2015 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Timeline of immunosuppression and immunosuppressive protocols. CNI: Cyclosporine A, Tacrolimus, Cyclosporine microemulsion, Tacrolimus released; MMF: mycophenolate mofetil; MPA: mycophenolic acid; Anti-IL-2-R: IL-2 receptors antibodies. Journal of Hepatology 2015 62, S170-S185DOI: (10.1016/j.jhep.2015.02.042) Copyright © 2015 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Mechanisms of graft rejection. (A) Damage to the graft during preservation and reperfusion activates the innate immune system including local NK and NK T cells that secrete proinflammatory cytokines. Dendritic cells (DC) migrate from the graft to recipient lymphoid tissue where they activate alloreactive T cells that enter lymphoid tissues from blood via high endothelial venules (HEV). Responding T cells proliferate, differentiate and secrete cytokines that promote activation of other effectors including monocytes/macrophages and eosinophils. Effector cells are recruited to the graft from the blood via activated hepatic endothelium and destroy donor cells, particularly bile duct cells and hepatocytes, by direct lysis (cytotoxic T lymphocytes and NK cells) cytokine-mediated effects or involvement of other cells including macrophages. Activated T cells provide help for alloantibody production by B cells leading to antibody-mediated graft damage and complement deposition on graft endothelium. (B) There are two types of allorecognition. Direct allorecognition occurs when T cells recognize intact foreign major histocompatible complex (MHC) molecules on donor antigen presenting cells (APC). This pathway dominates in acute graft rejection. T cells also recognize donor peptide fragments processed by and presented on self-MHC molecules (indirect allorecognition). This is important in chronic graft rejection but may have conflicting effects: providing T cell help for B cells leading to anti-graft antibodies but also activating regulatory T cells that limit graft damage and promote tolerance. Liver resident cells including sinusoidal endothelial cells and hepatocytes also present antigens but when they interact with naïve T cells the results is tolerance and in the case of endothelium a stop signal which prevents recruitment. (C) Effector cells are recruited to the graft by sequential interactions with activated hepatic sinusoidal endothelium. A brief tethering capture phase is followed by chemokine triggering of integrin (LFA-1 and VLA-4) mediated adhesion to ICAM-1 and VCAM-1 on activated endothelium which leads to stable adhesion and arrest followed by migration on and through the endothelial barrier into the graft, a process that involves chemokines, integrins and the atypical adhesion receptor vascular adhesion protein-1 (VAP-1) which has also been implicated in sialic acid dependent tethering. Journal of Hepatology 2015 62, S170-S185DOI: (10.1016/j.jhep.2015.02.042) Copyright © 2015 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Mechanisms of liver allograft tolerance. The liver contains multiple subsets of dendritic cells, which are professional antigen presenting cells, but that tend to maintain an immature and non-immunogenic phenotype. Kupffer cells, liver sinusoidal endothelial cells (LSEC), stellate cells and hepatocytes can also act as non-professional antigen presenting cells, but tend to deliver suboptimal T cell priming and induce dysfunctional T cells. Continuous exposure to lipopolysaccharides (LPS) by cells expressing Toll-like receptor-4 (TLR4), such as Kupffer cells and LSEC, results in downregulation of co-stimulatory molecules and production of immunosuppressive cytokines. Spontaneous liver allograft tolerance requires the presence of regulatory T cells, whose generation is promoted by the liver microenvironment. The liver releases substantial amounts of MHC molecules (particularly class I), which can exert immunomodulatory properties. Journal of Hepatology 2015 62, S170-S185DOI: (10.1016/j.jhep.2015.02.042) Copyright © 2015 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2015 62, S170-S185DOI: (10. 1016/j. jhep. 2015 Copyright © 2015 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2015 62, S170-S185DOI: (10. 1016/j. jhep. 2015 Copyright © 2015 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2015 62, S170-S185DOI: (10. 1016/j. jhep. 2015 Copyright © 2015 European Association for the Study of the Liver Terms and Conditions